News Tag: Q2

Correction: Lipidor publishes interim report for H1 2020

In the last press release, Lipidor published that the information and interim report was such that Lipidor is required to publish under the EU Market Abuse Regulation. This was incorrect as the interim report for H1 2020 contains no insider information. This has been corrected in this press release. Today, Lipidor AB publishes its interim […]

Lipidor publishes interim report for H1 2020

Today, Lipidor AB publishes its interim report for the period January – June 2020. The quarterly report is available on the company's website lipidor.se (https://lipidor.se/investors/financial-reports/interim-reports/) and in the attached pdf. Summary of the interim report – second quarter 2020 Lipidor has continuous positive ongoing out-licensing discussions with potential licensees. Preperations for initiation of the phase lll-study […]

Lipidor publicerar delårsrapport för H1 2020

Idag publicerar Lipidor AB sin delårsrapport för perioden januari – juni 2020. Kvartalsrapporten finns att hämta på bolagets hemsida lipidor.se (https://lipidor.se/investerare/finansiella-rapporter/delarsrapporter/) samt i form av bifogad pdf. Sammanfattning av delårsrapporten – andra kvartalet 2020 Lipidor har fortsatt pågående positiva utlicensieringsdiskussioner med potentiella licenstagare. Förberedelser för start av fas III-studien av AKP02 fortlöper enligt plan. Den planerade studien är […]

Arkiv